Foscan® uptake and tissue distribution in relation to photodynamic efficacy
暂无分享,去创建一个
P Baas | H. Oppelaar | M. Ruevekamp | F. Stewart | P. Baas | P. Cramers | H Oppelaar | M Ruevekamp | O Dalesio | F A Stewart | P Cramers | O. Dalesio
[1] P Baas,et al. Photodynamic therapy with meta‐tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study , 2001, The British journal of dermatology.
[2] H. Bergh,et al. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin. , 1997, Archives of otolaryngology--head & neck surgery.
[3] T. Mang,et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.
[4] D. Vernon,et al. Identification and Partial Characterization of an Unusual Distribution of the Photosensitizer meta‐Tetrahydroxyphenyl Chlorin (Temoporfin) in Human Plasma , 1999, Photochemistry and photobiology.
[5] S. Andersson-Engels,et al. Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats. , 1994, British Journal of Cancer.
[6] Q. Peng,et al. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. , 1995, Cancer research.
[7] P. Grosjean,et al. Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study. , 2001, Journal of photochemistry and photobiology. B, Biology.
[8] W. Star,et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.
[9] T. Patrice,et al. Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. , 1995, Journal of photochemistry and photobiology. B, Biology.
[10] T. Wieman,et al. Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. , 1990, Cancer research.
[11] A. Michael-Titus,et al. Distribution and Excretion of Radiolabeled Temoporfin in a Murine Tumor Model , 1996, Photochemistry and photobiology.
[12] H. Bergh,et al. Preliminary clinical results on a second generation photosensitizer: mTHPC , 1992 .
[13] Daniel Braichotte,et al. Clinical pharmacokinetic studies of tetra(meta‐hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths , 1995, International journal of cancer.
[14] C. Hadjur,et al. Pharmacokinetics of Tetra (m‐hydroxyphenyl)chlorin in Human Plasma and Individualized Light Dosimetry in Photodynamic Therapy , 1998, Photochemistry and photobiology.
[15] P B Cerrito,et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.
[16] J. J. Schuitmaker,et al. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. , 1995, British Journal of Cancer.
[17] C. Hadjur,et al. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval. , 1997, British Journal of Cancer.
[18] H. Bergh,et al. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers , 1996, Lasers in Medical Science.
[19] P. Speight,et al. Photodynamic therapy using mTHPC for malignant disease in the oral cavity , 1997, International journal of cancer.
[20] F. Wierrani,et al. Intraoperative Meso-Tetrahydroxyphenylchlorin-Based Photodynamic Therapy in Metastatic Gynecologic Cancer Tissue: Initial Results , 1997 .
[21] R. Whelpton,et al. DISTRIBUTION OF TEMOPORFIN, A NEW PHOTOSENSITIZER FOR THE PHOTODYNAMIC THERAPY OF CANCER, IN A MURINE TUMOR MODEL , 1995, Photochemistry and photobiology.
[22] M. C. Berenbaum,et al. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. , 1991, British journal of cancer.
[23] H. Oppelaar,et al. Foscan‐mediated photodynamic therapy for a peritoneal‐cancer model: Drug distribution and efficacy studies , 1997, International journal of cancer.
[24] U Althaus,et al. Effect of drug‐light interval on photodynamic therapy with meta‐tetrahydroxyphenylchlorin in malignant mesothelioma , 1993, International journal of cancer.
[25] T. Dougherty,et al. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. , 1979, Cancer research.
[26] G. Kenyon,et al. m-THPC photodynamic therapy for head and neck cancer , 1996, Lasers in Medical Science.
[27] O. Dalesio,et al. Does tumour uptake of Foscan determine PDT efficacy? , 1997, International journal of cancer.